Jpmorgan Chase & CO Incyte Corp Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Incyte Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 494,223 shares of INCY stock, worth $37.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

494,223

Previous 440,566 12.18%

Holding current value

$37.4 Million

Previous $25.1 Million 19.36%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$51.18 - $63.75 $2.75 Million - $3.42 Million	53,657 Added 12.18%	494,223 $30 Million
Q1 2024 May 10, 2024	SELL	$56.55 - $66.59 $4.58 Million - $5.39 Million	-80,904 Reduced 15.51%	440,566 $25.1 Million
Q4 2023 Feb 12, 2024	BUY	$52.16 - $64.19 $4.54 Million - $5.58 Million	86,949 Added 20.01%	521,470 $32.7 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $476,544 - $543,856	-8,249 Reduced 1.86%	434,521 $25.1 Million
Q2 2023 Aug 11, 2023	BUY	$60.95 - $75.51 $7.86 Million - $9.74 Million	128,951 Added 41.09%	442,770 $27.6 Million
Q1 2023 May 18, 2023	BUY	$70.23 - $86.01 $6.12 Million - $7.49 Million	87,103 Added 38.42%	313,819 $22.7 Million
Q1 2023 May 11, 2023	SELL	$70.23 - $86.01 $4.68 Million - $5.73 Million	-66,569 Reduced 22.7%	226,716 $16.4 Million
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $2.92 Million - $3.66 Million	43,464 Added 17.4%	293,285 $23.6 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $35,406 - $44,330	-535 Reduced 0.21%	249,821 $16.6 Million
Q2 2022 Aug 11, 2022	SELL	$66.18 - $83.18 $3.1 Million - $3.9 Million	-46,877 Reduced 15.77%	250,356 $19 Million
Q1 2022 May 11, 2022	BUY	$66.02 - $79.71 $10.9 Million - $13.2 Million	165,031 Added 124.83%	297,233 $23.6 Million
Q4 2021 Feb 10, 2022	SELL	$63.34 - $74.11 $11 Million - $12.9 Million	-173,661 Reduced 56.78%	132,202 $9.7 Million
Q3 2021 Nov 12, 2021	BUY	$68.67 - $84.02 $21 Million - $25.7 Million	305,863 New	305,863 $21 Million

Others Institutions Holding INCY

# of Institutions

627

Shares Held

197M

Call Options Held

766K

Put Options Held

476K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Incyte Corp Transaction History